Patent Yard Sign in
Canadian application, no grantCanada

Glycoconjugates from modified camptothecin derivates (20-o-linkage)

CA 2267328 A1 · Owner: Sperzel, Michael · Inventors: Lerchen, Hans-Georg; Sperzel, Michael; Von Dem Bruch, Karsten

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

Disclosed are glycoconjugates from modified camptothecin derivates where at , least a glucidic component is linked to the 20-hydroxyl group of a camptothecin derivate. Also disclosed are their preparation and their use as pharmaceutical products, especially against cancer diseases.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed September 17, 1997. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended September 17, 2017.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by September 17, 2019.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledSeptember 17, 1997
GrantedNo grant recorded
Term endedSeptember 17, 2017
Patent numberCA 2267328 A1
Classification (IPC)C07H17/00 +2 more

Timeline

Timeline From CIPO dates

1998200020022004200620082010201220142016Application filedSep 17, 1997Term endedSep 17, 2017

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.